---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-007474"
form_type: "8-K"
ticker: "BAX"
cik: "0000010456"
company_name: "BAXTER INTERNATIONAL INC"
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T02:54:23.803356+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Baxter Q4 GAAP EPS loss ($2.01), adj. $0.44; sales $2.97B +8%; div cut to $0.01

## Summary
- Q4 sales $2.97B (+8% reported, +3% operational); GAAP diluted EPS loss ($2.01), adjusted diluted EPS $0.44.
- Board appoints Michael R. McDonnell (former Biogen CFO); directors Cathy Smith and Stephen Rusckowski resign effective Feb 13.
- Quarterly dividend declared at $0.01 per share, payable April 1, 2026 to holders of record Feb 27, 2026.
- CEO Hider: Q4 results missed expectations; new operating model aims to simplify organization and accelerate innovation.

## SEC filing metadata
- accession: 0001628280-26-007474
- form_type: 8-K
- ticker: BAX
- cik: 0000010456
- company_name: BAXTER INTERNATIONAL INC
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10456/000162828026007474/0001628280-26-007474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10456/000162828026007474/bax-20260210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-007474
- JSON: https://secwatch.observer/filing/0001628280-26-007474.json
- Plain text: https://secwatch.observer/filing/0001628280-26-007474.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.